GLP-1 Drug Breaks Liver Cancer's Drug Resistance via Metabolic Pathway
GLP-1 receptor agonists may overcome Lenvatinib resistance in hepatocellular carcinoma by targeting a key glycolytic vulnerability.
675 articles in this topic
GLP-1 receptor agonists may overcome Lenvatinib resistance in hepatocellular carcinoma by targeting a key glycolytic vulnerability.
Researchers propose a unified model classifying cancer-associated fibroblasts by molecular phenotype and spatial location to guide precision therapy.
Corticosterone triggered by gut microbiome-derived phage DNA disables B cell tumor immunity, revealing a stress-cancer axis.
A phase I trial tests SD-101, nivolumab, and radiation together against metastatic pancreatic cancer that has stopped responding to chemo.
A new study finds elevated LDL, total cholesterol, and triglycerides significantly raise colorectal adenoma risk — a key cancer precursor.
A Chinese cohort study reveals the cancer risk landscape for patients with autoimmune gastritis, a condition frequently underdiagnosed in Asian populations.
Spatial-EV-seq charts where cancer-shielding vesicles cluster in tissue, exposing why immunotherapy fails in some tumor zones.
A sex-specific GABA signaling pathway supercharges immune suppression in female glioblastoma, revealing a potential new immunotherapy target.
A Phase 1/2 trial tests a custom cancer vaccine paired with checkpoint inhibitors in patients with advanced solid tumors.
The FDA has greenlighted a new active sunscreen ingredient, the first approval of its kind in years, expanding UV protection options.
University of Pittsburgh researchers discovered H5N1 targets mammary tissue in dairy cows due to concentrated glycan receptors — a finding that could predict future outbreaks.
A small genetic change in bat viruses may enable them to infect humans.